News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Phase 1 data from the auristatin HER2 ADC PF-06804103 highlight the importance of optimizing the toxicity profile of novel ADCs – Paolo Tarantino
Photo from Paolo Tarantino/Twitter
Jul 9, 2023, 09:59

Phase 1 data from the auristatin HER2 ADC PF-06804103 highlight the importance of optimizing the toxicity profile of novel ADCs – Paolo Tarantino

Phase 1 data from the auristatin HER2 ADC PF-06804103 highlight the importance of optimizing the toxicity profile of novel ADCs. The drug showed relevant activity (ORR 30%) for HER2+ BC & GC, but nearly half of the pts discontinued treatment for toxicity.

For article: Click here

Source: Paolo Tarantino/Twitter

#cancer patients auristatin cancer drug OncoDaily Oncology Paolo Tarantino toxicity
Special Coverage
Blog
May 21, 2025, 07:53
Helena Linardou: Last Chance to Vote for the IASLC Board Election by May 22
Blog
May 21, 2025, 07:32
Ruben Mesa: Grateful to Take On a New Role as Clinical Leader for Advocate Health’s National Cancer Program
Blog
May 21, 2025, 07:25
Benedikt Westphalen Shares Final ESMO Recommendations for Molecular Tumour Boards
Blog
May 21, 2025, 07:16
Albert Koong: A Gathering of MD Anderson Physicists Could Disturb the Force
Blog
May 21, 2025, 07:09
Daniel Sumarriva: I’m Starting a New Position as Executive Medical Director at SAGA Diagnostics
Blog
May 21, 2025, 07:01
Together, She Changed Everything: Martine Piccart’s Fight Against Breast Cancer - CancerWorld
Blog
May 21, 2025, 06:44
Vivek Subbiah: Clinical Trials are Essential for Medical Advancement
Blog
May 21, 2025, 06:37
Hesham ElGhazaly: First Cancer Planners Forum by UICC
Blog
May 21, 2025, 06:28
Irina Ghazaryan Explores Uzbekistan's Healthcare Market at Plug and Play Expo
Blog
May 21, 2025, 06:19
George Kapetanakis: Honored to Participate at Cancer Planners Forum!
Blog
May 21, 2025, 06:06
Mandy Davis Aitken: We are Getting Ready for ASCO25, Are you?
Blog
May 21, 2025, 06:00
Charles Mullighan Has Been Elected as a Fellow of The Royal Society of London - St. Jude Children's Research Hospital